Drugs encased in nanoparticles travel to tumors on the surface of immune-system cells

Clinical trials using patients' own immune cells to target tumors have yielded promising results. However, this approach usually works only if the patients also receive large doses of drugs designed to help immune cells multiply rapidly, and those drugs have life-threatening side effects.

Read the whole article on Physorg

More from Physorg